Medication info
Rosabecil Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Rosabecil Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Kunil Biofarm Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202002053 · Approved 2020.03.24 · Insurance code 073000580

Summary

Main use
Treatment of hypertension when control with monotherapy is inadequate or initial combination therapy is required
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or losartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Administration of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this drug as initial treatment is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, administration of this drug is not recommended.

Ingredients

Manufacturer
Kunil Biofarm Co., Ltd.

Efficacy & effects

Treatment of hypertension when control with monotherapy is inadequate or initial combination therapy is required

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure is not adequately controlled with monotherapy using amlodipine or losartan. Additionally, it is prescribed as initial therapy when patients with Stage 2 hypertension require combination therapy to reach the target blood pressure. Thus, this drug helps to effectively manage hypertension and control blood pressure within a normal range.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or losartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Administration of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this drug as initial treatment is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, administration of this drug is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Caution is required when first administering it to patients with reduced blood volume as hypotension may occur, and it is advisable not to use this medication in such patients. It should not be taken by those allergic to its active ingredients or similar compounds. It is not administered to patients with severe liver dysfunction, severe aortic stenosis, or those in shock. It should be used with caution in patients with reduced blood volume or moderate to severe renal impairment, and in those with hyperkalemia. Side effects such as dizziness, headache, drowsiness, swelling, dyspepsia, itching, and others may occur, and if unusual symptoms arise, consultation with a physician is necessary. If blood pressure drops sharply leading to loss of consciousness or shock, use should be discontinued immediately and treatment sought. Care is needed when performing high-risk work or driving. Patients with liver or kidney impairment should consult with a healthcare provider before using this medication, and care should be taken when taken with potassium-sparing diuretics or potassium supplements due to possible increases in potassium levels. If taken with other antihypertensives, blood pressure-lowering effects may increase, so it should be taken as directed by a healthcare provider. This medication is not recommended during breastfeeding, and safety and efficacy in children under 18 years of age have not been established, so it is not recommended. In cases of overdose, blood pressure may drop severely or heart rhythm may become irregular, so the prescribed dose should be strictly adhered to and medical attention sought in case of suspected overdose. This medication should be kept out of reach of children and not transferred to other containers for safety.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 174 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival hyperemia
  • increased urination
  • fatigue
  • edema
  • vasculitis
  • tension increase
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disorders
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus obstruction
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neural hypersensitivity
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • urethral infection
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • hypotension
  • shock symptoms
  • loss of consciousness
  • angioedema
  • vasculitis
  • rhabdomyolysis
  • taste disorders
  • dry cough
  • erythema
  • hyperkalemia
  • hyponatremia
  • elevated serum creatinine
  • elevated liver enzymes
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock state
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is best kept at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.